We serve (3S)-pyrrolidine-3-carboxylic acid CAS:72580-53-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: (3S)-pyrrolidine-3-carboxylic acid
CAS.NO:72580-53-1
Molecular Formula:C5H9NO2
Molecular Weight:115.13000
Synonyms:
(S)-|A-Proline
(S)-Pyrrolidine-3-carboxylicacid
(R)-Pyrrolidine-3-carboxylicacid
Physical and Chemical Properties:
Density: 1.186g / cm3
Boiling point: 252.2ºC at 760 mmHg
Flash point: 106.3ºC
Refractive index: 1.487
Specification:
Appearance:White or off white Powder
Purity:≥99.0%
Water:≤0.5%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:An important raw material and intermediate used in Organic Synthesis,Pharmaceuticals.
Contact us for information like (3S)-pyrrolidine-3-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(R)-Pyrrolidine-3-carboxylicacid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-|A-Proline Use and application,(S)-|A-Proline technical grade,usp/ep/jp grade.
Related News: “So far, the finding is still under preliminary study, and a large number of experiments is needed to test if it is effective on patients,” it said, citing the WHO in saying that no proven effective drugs to prevent or treat the Wuhan coronavirus are currently available.3-Fluoro-5-bromotoluene manufacturer “So far, the finding is still under preliminary study, and a large number of experiments is needed to test if it is effective on patients,” it said, citing the WHO in saying that no proven effective drugs to prevent or treat the Wuhan coronavirus are currently available.4-aminobenzamide supplier ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.2-Fluoropyridine vendor The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.
